CNSP NASDAQ
CNS Pharmaceuticals, Inc.
1W: +7.9%
1M: -11.5%
3M: +6.8%
YTD: +0.4%
1Y: -38.9%
3Y: -100.0%
5Y: -100.0%
$5.32
+0.08 (+1.61%)
Weekly Expected Move ±7.5%
$5
$5
$5
$6
$6
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
6 relationships6
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2024-02-02
Earliest Filing
2025-05-15
Latest Filing
partner: 6
Counterparties (Filed by CNSP)
6 relationshipsCompanies named in CNSP's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| A.G.P./Alliance Global Partners | — | partner | Placement agent for the public offering of common stock and warrants | 2025-05-15 | View |
| A.G.P./Alliance Global Partners | — | partner | Placement agent for the registered direct offering of common stock and pre-funded warrants. | 2024-10-24 | View |
| A.G.P./Alliance Global Partners | — | partner | Sales agent for the Company's at-the-market offering of common stock | 2024-07-26 | View |
| A.G.P./Alliance Global Partners | — | partner | Placement agent for the public offering of common stock and warrants | 2024-02-02 | View |
| Maxim Group LLC | MMS | partner | Placement agent for the public offering of common stock and warrants | 2024-02-02 | View |
| JonesTrading Institutional Services LLC | — | partner | Counterparty to the Capital on Demand Sales Agreement | 2024-02-02 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-10-02 | Officer/Director Change; Shareholder Vote; Exhibits | View | |
| 2026-07-02 | Regulation FD; Exhibits | View | |
| 2026-05-04 | Material Agreement; Unregistered Equity Sales; Officer/Director Change; Exhibits | Agreement | View |
| 2026-03-11 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-03-02 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2026-02-17 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-12-17 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-11-21 | Departure/Election of Directors; Appointment of Officers; Amendments to Articles of Incorporation or | View | |
| 2025-07-22 | Material Modification to Rights of Security Holders; Amendments to Articles of Incorporation or Byla | View | |
| 2025-07-15 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-05-15 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-04-09 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-03-31 | Other Events | View | |
| 2025-03-20 | Other Events; Financial Statements and Exhibits | View | |
| 2025-02-21 | Material Modification to Rights of Security Holders; Other Events; Financial Statements and Exhibits | View | |
| 2025-01-03 | Regulation FD Disclosure; Other Events; Financial Statements and Exhibits | View | |
| 2024-12-11 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2024-12-03 | Submission of Matters to a Vote of Security Holders | View | |
| 2024-11-01 | Other Events | View | |
| 2024-10-24 | Entry into Material Definitive Agreement; Other Events; Financial Statements and Exhibits | Agreement | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR